Thermo Fisher Scientific (TMO) Reports Strong Third Quarter 2012 Revenue and EPS Results  
10/24/2012 9:08:45 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 29, 2012.

Third Quarter Highlights

Adjusted earnings per share (EPS) grew 11% to a third quarter record of $1.19.

Revenue increased 5% to a record $3.09 billion for the third quarter.

Adjusted operating income rose 5% to $576 million.

Year-to-date free cash flow increased 39% to $1.20 billion.

Launched new immunoassays, analyzers and controls for specialty diagnostics, such as drugs-of-abuse testing, at AACC clinical laboratory expo.

Opened new molecular biology Center of Excellence to serve global life sciences customers and strengthen presence in high-growth Eastern European markets.